A Serologic Study of Cytomegalovirus Infections Associated with Blood Transfusions

Abstract
The development of complement-fixing antibody to cytomegalovirus was determined in 152 prospectively studied patients. Seven per cent of 59 patients who received only a single unit of blood, 21 per cent of 72 patients with multiple transfusions, and 52 per cent of 21 immunosuppressed transplant recipients showed seroconversion an average of eight weeks after transfusion. The immunosuppressed transplant patients were found to have a significantly enhanced immune response.